Skip to main content

Table 1 Summary of participants’ characteristics

From: Mass spectrometry detection of inhaled drug in distal fibrotic lung

  Ipratropium bromide (N* = 7)
Age in Years [Mean (SD)] 62.1 (5.98)
Male [n (%)] 3 (43)
BMI (kg/m2) [Mean (SD)] 31.11 (3.191)
Height (cm) [Mean (SD)] 168.71 (16.039)
FVC [Mean (SD)]  2.58 (1.161)
% predicted FVC [Mean (SD)]  73.75 (12.863)
FEV1 [Mean (SD)]  2.12 (0.773)
% predicted FEV1 [Mean (SD)]  77.07 (11.256)
MDT diagnosis of study completers Study completers (N = 5)
IPF/probable IPF [n (%)] 3 (60)
NSIP/fibrotic NSIP [n (%)] 2 (40)
  1. BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume at 1 s, MDT multidisciplinary team, IPF idiopathic pulmonary fibrosis, NSIP non-specific interstitial pneumonia
  2. Note 1: *One participant had to be re-enrolled
  3. Note 2: As this was a non-quantitative, proof of concept study the impact of the participant’s characteristics was not designed to be taken into consideration